Literature DB >> 17436234

Immunopathogenesis of respiratory syncytial virus bronchiolitis.

Berkeley L Bennett1, Roberto P Garofalo, Stanley G Cron, Yashoda M Hosakote, Robert L Atmar, Charles G Macias, Pedro A Piedra.   

Abstract

BACKGROUND: The objective of this study was to elucidate the relation between respiratory syncytial virus (RSV) infection and cytokine/chemokine concentrations, as well as the impact that these factors have on the severity of bronchiolitis.
METHODS: Children <24 months old who presented to the emergency department with clinical symptoms of bronchiolitis were prospectively enrolled in the study. Nasal-wash samples were analyzed to identify viral pathogens and to quantify RSV and cytokine/chemokine concentrations. Severe cases of disease were defined as those requiring hospitalization, and severity was further determined on the basis of the duration of supplemental-oxygen and/or intravenous-fluid therapy.
RESULTS: A total of 101 children were enrolled, 63 of whom were infected with RSV and 13 of whom were infected with other respiratory viruses; in 22 children, no virus was detected. RSV bronchiolitis was associated with a greater inflammatory response than was non-RSV bronchiolitis, although RSV infection was not associated with more-severe disease. Levels of interleukin (IL)-6, IL-8, IL-10, interferon (IFN)-gamma, and macrophage inflammatory protein (MIP)-1beta were significantly inversely correlated with the duration of supplemental-oxygen therapy.
CONCLUSION: The robust inflammatory response associated with RSV infection does not contribute to the severity of RSV bronchiolitis any more than it contributes to the severity of non-RSV bronchiolitis. Elevated levels of proinflammatory mediators IL-6, IL-8, IFN-gamma, and MIP-1beta, as well as of the regulatory cytokine IL-10, may be protective against hypoxia in bronchiolitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17436234     DOI: 10.1086/515575

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  Airway IFN-γ production during RSV bronchiolitis is associated with eosinophilic inflammation.

Authors:  Chang Keun Kim; Zak Callaway; Young Yull Koh; Soo-Hee Kim; Takao Fujisawa
Journal:  Lung       Date:  2011-12-13       Impact factor: 2.584

2.  Resveratrol-mediated gamma interferon reduction prevents airway inflammation and airway hyperresponsiveness in respiratory syncytial virus-infected immunocompromised mice.

Authors:  Na Zang; Xiaohong Xie; Yu Deng; Shengde Wu; Lijia Wang; Caijing Peng; Simin Li; Ke Ni; Yan Luo; Enmei Liu
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

3.  Robust Cytokine and Chemokine Response in Nasopharyngeal Secretions: Association With Decreased Severity in Children With Physician Diagnosed Bronchiolitis.

Authors:  Erin G Nicholson; Chelsea Schlegel; Roberto P Garofalo; Reena Mehta; Margaret Scheffler; Minghua Mei; Pedro A Piedra
Journal:  J Infect Dis       Date:  2016-05-18       Impact factor: 5.226

4.  Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.

Authors:  Dora Estripeaut; Juan Pablo Torres; Cynthia S Somers; Claudia Tagliabue; Shama Khokhar; Vijay G Bhoj; Steve M Grube; Aneta Wozniakowski; Ana M Gomez; Octavio Ramilo; Hasan S Jafri; Asuncion Mejias
Journal:  J Infect Dis       Date:  2008-11-15       Impact factor: 5.226

5.  The severity of Puumala hantavirus induced nephropathia epidemica can be better evaluated using plasma interleukin-6 than C-reactive protein determinations.

Authors:  Tuula K Outinen; Satu M Mäkelä; Ilpo O Ala-Houhala; Heini Sa Huhtala; Mikko Hurme; Antti S Paakkala; Ilkka H Pörsti; Jaana T Syrjänen; Jukka T Mustonen
Journal:  BMC Infect Dis       Date:  2010-05-25       Impact factor: 3.090

6.  Respiratory syncytial virus (RSV) RNA loads in peripheral blood correlates with disease severity in mice.

Authors:  Juan Pablo Torres; Ana M Gomez; Shama Khokhar; Vijay G Bhoj; Claudia Tagliabue; Michael L Chang; Peter A Kiener; Paula A Revell; Octavio Ramilo; Asuncion Mejias
Journal:  Respir Res       Date:  2010-09-15

7.  Attenuation of live respiratory syncytial virus vaccines is associated with reductions in levels of nasal cytokines.

Authors:  Ruth A Karron; Bhagvanji Thumar; Elizabeth Schappell; Ursula J Buchholz; Peter L Collins
Journal:  J Infect Dis       Date:  2013-03-12       Impact factor: 5.226

8.  Nasopharyngeal Microbiota, Host Transcriptome, and Disease Severity in Children with Respiratory Syncytial Virus Infection.

Authors:  Wouter A A de Steenhuijsen Piters; Santtu Heinonen; Raiza Hasrat; Eleonora Bunsow; Bennett Smith; Maria-Carmen Suarez-Arrabal; Damien Chaussabel; Daniel M Cohen; Elisabeth A M Sanders; Octavio Ramilo; Debby Bogaert; Asuncion Mejias
Journal:  Am J Respir Crit Care Med       Date:  2016-11-01       Impact factor: 21.405

9.  Respiratory syncytial virus and reactive airway disease.

Authors:  Matthew T Lotz; Martin L Moore; R Stokes Peebles
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis.

Authors:  Carolina Scagnolari; Fabio Midulla; Alessandra Pierangeli; Corrado Moretti; Enea Bonci; Rosaria Berardi; Daniela De Angelis; Carla Selvaggi; Paola Di Marco; Enrico Girardi; Guido Antonelli
Journal:  Clin Vaccine Immunol       Date:  2009-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.